Our weekly wrap-up of antimicrobial stewardship & antimicrobial resistance scans
NIAID funds development of test for detecting AMR genes
Originally published by CIDRAP News Jan 9
The National Institute of Allergy and Infectious Diseases (NIAID) has awarded $1.5 million to Phase Genomics of Seattle, Washington, to develop a low-cost, culture-free platform for detecting antimicrobial resistance (AMR) genes.